MedTrace Logo

Young Adult EC Use and Respiratory Outcomes

NCT04395274 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2024-12-12

Study results available
· View outcomes & findings →

Summary

E-cigarette (EC) use continues to increase among youth, and EC may be detrimental to youth respiratory health. Public health officials and the Food and Drug Administration (FDA) can now regulate ECs. The proposed study uses naturalistic assessments called ecological momentary assessment (EMA) to understand how ECs use may impact the respiratory health of youth and young adult users compared to never-using peers.

Conditions

  • E Cig Use

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Food and Drug Administration (FDA)

    collaborator FED

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Alayna Tackett, PhD · The Ohio State Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-15
Primary Completion
2024-02-21
Completion
2024-02-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04395274 on ClinicalTrials.gov